PMID: 9526964Apr 4, 1998Paper

Sibutramine reduces food intake in non-dieting women with obesity

Obesity Research
B J RollsJ S Ulbrecht

Abstract

Sibutramine (SIB), an inhibitor of serotonin and noradrenaline reuptake, has been shown in clinical trials to be associated with a dose-related decrease in bodyweight. This double-blind, placebo-controlled, Latin square crossover study examined whether the effect on bodyweight could be due in part to a reduction in daily food intake. Twelve non-dieting, women with obesity (body mass index of 30.5 to 41.9) received three treatments (0 [matching placebo], 10, or 30 mg SIB/day) for 14 days, with 14-day washout periods in between. On days 7 and 14, participants came to the laboratory to eat breakfast, lunch, and dinner so that daily energy and macronutrient intakes and ratings of hunger and satiety could be measured. Significant reductions occurred in food intake (both grams and energy) over the 14-day study period. On day 7, SIB 30 reduced intake significantly by 1762 kJ (23% reduction from placebo), and on day 14, both SIB 10 and SIB 30 significantly reduced intake compared with placebo (SIB 10, 19% reduction [1490 kJ]; SIB 30, 26% reduction [2079 kJ]). On day 7, the percentage of energy consumed from carbohydrate increased significantly with the 30-mg dose (56.7%) compared with that of placebo (51.4%), with a reciprocal decrease...Continue Reading

References

May 1, 1979·Psychological Medicine·D M Garner, P E Garfinkel
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·W R BuckettG P Luscombe
Jan 1, 1985·Journal of Psychosomatic Research·A J Stunkard, S Messick
Jan 1, 1974·Modern Problems of Pharmacopsychiatry·A T Beck, A Beamesderfer
Nov 1, 1993·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J WurtmanR Tsay
Nov 1, 1995·Obesity Research·J E BlundellJ C Halford
Nov 1, 1995·Obesity Research·D H RyanG A Bray

❮ Previous
Next ❯

Citations

Dec 24, 2011·Psychopharmacology·Kerstin M OltmannsHendrik Lehnert
Aug 29, 2006·European Journal of Clinical Pharmacology·Jean-Philippe Chaput, Angelo Tremblay
Nov 26, 2003·Physiology & Behavior·M LeBlanc, L Thibault
May 15, 2002·European Journal of Pharmacology·Carla A Luque, Jose A Rey
Mar 15, 2000·Physiology & Behavior·D ChapelotC Hanotin
Mar 15, 2003·Clinical Therapeutics·Wilson Y S LeungBrian Tomlinson
Apr 24, 2001·Pharmacology & Therapeutics·J C ClaphamM Tadayyon
Feb 11, 2003·Peptides·Kouji MatsumotoKeiji Wada
May 18, 2013·Nutrition Research Reviews·M M HetheringtonH C M Van Trijp
Jul 31, 2003·American Journal of Respiratory and Critical Care Medicine·Gary D Foster
Mar 16, 2005·Treatments in Endocrinology·Michael Hamilton
Apr 4, 2002·Journal of Endocrinological Investigation·A GokcelR Anarat
May 30, 2009·Vascular Health and Risk Management·Konstantinos TziomalosThemistoklis Tzotzas
Mar 12, 2004·Expert Opinion on Pharmacotherapy·Walker S Carlos Poston, John P Foreyt
Apr 7, 2005·Current Medical Research and Opinion·T D FilippatosM S Elisaf
May 15, 2007·Gastroenterology·George A Bray, Donna H Ryan
Oct 19, 2005·Appetite·Jason C G Halford
Oct 22, 2003·Primary Care·Donna H Ryan
Aug 4, 1998·Obesity Research·T A WaddenJ L Aber
Mar 12, 2002·Obesity Research·Alison M StrackGerard J Hickey
Jun 11, 2002·Obesity Research·Suzanne Phelan, Thomas A Wadden
May 2, 2001·Obesity Research·R D StarlingD H Sullivan
Apr 15, 2008·Annual Review of Nutrition·Mary-Ellen HarperMartin D Brand
Jul 18, 2002·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·E Nisoli, M O Carruba
Sep 24, 2004·The British Journal of Nutrition·Louise ThibaultMargriet S Westerterp-Plantenga
Feb 24, 2005·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·I Y N I KarabacakM Arslan
Aug 30, 2008·Journal of Psychopharmacology·J C G HalfordJ P H Wilding
Dec 8, 2004·International Journal of Obesity : Journal of the International Association for the Study of Obesity·V HainerM Wagenknecht
Apr 15, 2000·Nature·G A Bray, L A Tartaglia
Sep 23, 2010·European Journal of Clinical Nutrition·H J SmitP J Rogers
Jul 31, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·S Bérubé-ParentA Tremblay
Jan 28, 2005·The Cochrane Database of Systematic Reviews·S L NorrisJ Lau
May 4, 2007·Periodontology 2000·Christine Seel Ritchie
Dec 17, 2009·Nature Reviews. Endocrinology·John Blundell
Mar 18, 2010·Nature Reviews. Endocrinology·Jason C G HalfordJoanne A Harrold
Jul 2, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·B BarkelingS Rössner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.